StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Avenue Therapeutics's total debt was $0 at Dec 31, 2017. For fiscal 2017 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2017Dec 31, 2017$0-100.0%
FY2016Dec 31, 2016$1.83M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$394.00K–
Q4 FY2016Dec 31, 2016$1.83M–

More Avenue Therapeutics figures

See a number that looks wrong?